Cronos (CRON) Total Current Liabilities (2016 - 2026)
Cronos (CRON) recorded quarterly Total Current Liabilities of $42.4 million in Q1 2026, down 11.97% quarter-over-quarter from $48.2 million in Q4 2025, and up 28.36% on a YoY basis from $33.0 million in Q1 2025.
Cronos (CRON) Total Current Liabilities (2016 - 2026) Analysis & Trends
Cronos' Total Current Liabilities history runs 11 years deep, the most recent figure standing at $42.4 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 28.36% year-over-year to $42.4 million; the TTM figure through Mar 2026 stood at $42.4 million (up 28.36% YoY), while the FY2025 annual figure was $48.2 million, down 3.04% from the prior year.
- Total Current Liabilities was $42.4 million for Q1 2026 at Cronos, down from $48.2 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $49.7 million in Q4 2024 to a low of $5.6 million in Q4 2022.
- Historically, Total Current Liabilities has averaged $35.9 million across 5 years, with a median of $38.0 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Total Current Liabilities slumped 86.7% in 2022, then soared 640.19% in 2023.
- A 5-year view of Total Current Liabilities shows it stood at $5.6 million in 2022, then jumped by 640.19% to $41.4 million in 2023, then climbed by 20.05% to $49.7 million in 2024, then declined by 3.04% to $48.2 million in 2025, then slipped by 11.97% to $42.4 million in 2026.
- The last three Total Current Liabilities figures came in at $42.4 million (Q1 2026), $48.2 million (Q4 2025), and $41.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 333.17 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 618.78 Mn |
| 10 | Cronos | 1.06 Bn | 284.85 Mn | 19.15 Mn | 42.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.42 Mn |
| Dec 31, 2025 | 48.19 Mn |
| Sep 30, 2025 | 41.07 Mn |
| Jun 30, 2025 | 37.61 Mn |
| Mar 31, 2025 | 33.05 Mn |
| Dec 31, 2024 | 49.70 Mn |
| Sep 30, 2024 | 39.56 Mn |
| Jun 30, 2024 | 33.06 Mn |
| Mar 31, 2024 | 33.42 Mn |
| Dec 31, 2023 | 41.40 Mn |
| Sep 30, 2023 | 30.58 Mn |
| Jun 30, 2023 | 27.93 Mn |
| Mar 31, 2023 | 29.13 Mn |
| Dec 31, 2022 | 5.59 Mn |
| Sep 30, 2022 | 37.97 Mn |
| Jun 30, 2022 | 39.20 Mn |
| Mar 31, 2022 | 40.25 Mn |
| Dec 31, 2021 | 13.46 Mn |
| Sep 30, 2021 | 69.60 Mn |
| Jun 30, 2021 | 200.60 Mn |